Sangwoo Lee
DIRECTOR
Elastagen
Australia
Biography
Sangwoo has 18 years of industrial experiences in diverse area and companies in IT including Samsung Electronics, Dasan networks, and successful venture startups of Neomtel and Polidigm. His diverse area of experience covers from IT engineering skills like sw design/development, algorithm design/implementation, network protocol to service planning and company management. In startups of Neomtel and Polidigm, Sangwoo led the core engineering development as CTO. Neomtel introduced a new service concept of mobile image compression and transmission at 2000 and its graphice technology became a de-facto standard in Korea at early 2000s. The technology was adapted by Qualcomm later and the company went IPO at 2007. Sangwoo is responsible for global expansion of Korea Investment Partners and actively exploring cross-border investments. Current investment portfolio of Sangwoo is diverse from BIO-Healthcare companies like Elastagen, Auris Surgical Robotics, KAHR to IT companies. Sangwoo received his B.S. and M.S. in Control and Instrumentation Engineering from Seoul National University . He is a fluent English speaker.
Research Interest
Pharmaceutics & Biopharmaceutics Drug Targeting & Drug Development Pharmaceutical Research Pharmaceutical Materials Pharmaceutical Formulations Pharmaceutical Biotechnology Pharmaceutical Nanotechnology Pharmaceutical Technology Pharmaceutical Manufacturing Pharmaceutical Engineering Drug Delivery Technologies Medical Devices Drug Regulatory Affairs Pharmaceutical Management